Application of an ex-vivo drug sensitivity platform towards achieving complete remission in a refractory T-cell lymphoma

• Main Authors: de Mel, S., Rashid, M.B.M., Zhang, X.Y., Goh, J., Lee, C.T., Poon, L.M., Chan, E.H.L., Liu, X., Chng, W.J., Chee, Y.L., Lee, J., Yuen, Y.C., Lim, J.Q., Chia, B.K.H., Laurensia, Y., Huang, D.C., Pang, W.L., Cheah, D.M.Z., Wong, E.K.Y., Ong, C.K., Tang, T., Lim, S.T., Ng, S.B., Tan, S.Y., Loi, H.-Y., Tan, L.K., Chow, E.K., Jeyasekharan, A.D.
• Other Authors: MEDICINE
• Format: Letter
• Published: Springer Nature 2021
• Online Access: https://scholarbank.nus.edu.sg/handle/10635/198705
• Institution: National University of Singapore

10.1038/s41408-020-0276-7